Mixed-Mode Chromatography Ligands for High-Yield Protein Purification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current protein purification methods, particularly for immunoglobulins and enzymes, face challenges such as low yield, high costs due to expensive separation media, leaching of media into the product, and environmental concerns related to disposal of extraneous materials.

Innovation Solution

A mixed-mode chromatography system combining cationic exchange (CEX) and hydrophobic functionalities with a large-pore support matrix, utilizing a ligand with a 1,3-dioxoisoindolin-2-yl group and a carboxyl group, which is coupled to the matrix via a hydrophobic group, allowing for efficient protein binding and elution.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional separation media are used for protein purification, then the purification process can be performed, but the cost is high and the yield is low

Engineering Contradiction:
Improvepurification yieldVSAvoidcost of separation media
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The patent combines cation exchange and hydrophobic interaction functionalities into a single mixed-mode ligand structure (1,3-dioxoisoindolin-2-yl with carboxyl group). This merging of two separation mechanisms into one medium enables high-yield purification while reducing the need for multiple separation steps and expensive specialized media.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The invention uses a composite ligand structure that integrates both ionic (carboxyl group for cation exchange) and hydrophobic (1,3-dioxoisoindolin-2-yl group) properties. This composite material approach creates a single separation medium that performs multiple purification functions, improving yield while controlling costs.

Inventive Principle:
Principle #40Composite materials

2Reliability

If conventional separation media are used, then protein purification can be achieved, but the media may leach into the product

Engineering Contradiction:
Improveproduct purityVSAvoidmedia leaching
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent employs a porous support matrix with controlled pore size (0.5-2.0 microns) that provides mechanical stability and prevents ligand leaching. The porous structure allows protein access to binding sites while retaining the ligand firmly, ensuring product purity without contamination from separation media.

Inventive Principle:
Principle #31Porous materials

Solution Approach 2:

The ligand is firmly coupled to the porous support matrix through a stable linkage, creating an intermediary structure that prevents direct contact and potential leaching of the active ligand into the product. The support matrix acts as a stable carrier that holds the ligand in place during purification operations.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If conventional chromatography media are used, then protein separation can be performed, but environmental disposal becomes problematic

Engineering Contradiction:
Improveseparation effectivenessVSAvoidenvironmental disposal issues
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The mixed-mode ligand with its stable structure and firm coupling to the porous support enables efficient protein binding and elution, allowing for effective separation while the stable construction facilitates proper disposal or recovery of the separation medium, reducing environmental impact.

Inventive Principle:
Principle #34Discarding and recovering

4Productivity

If a mixed-mode chromatography system is used, then highly purified immunoglobulins can be achieved in high yield, but the ligand structure becomes more complex

Engineering Contradiction:
Improvepurification efficiencyVSAvoidligand structure complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent merges cation exchange and hydrophobic interaction functionalities into a single integrated ligand molecule (1,3-dioxoisoindolin-2-yl with carboxyl group). This consolidation achieves high purification efficiency in a single pass while managing structural complexity through thoughtful molecular design rather than using multiple separate components.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables highly purified immunoglobulins to be achieved in high yield with a single pass through the separation medium, while also providing a novel separation medium and method of ligand attachment, enhancing hydrophobic and ion exchange properties.

Implementation Method 1

a mixed-mode chromatography system that combines cationic exchange (CEX) and hydrophobic functionalities

Methodology Applied
Scientific EffectCationic exchange: Ion Exchange

Implementation Method 2

The ligands disclosed in this application exhibit moderate hydrophobicity and a significant dipole moment

Methodology Applied
Scientific EffectHydrophobic interaction: Hydrophobe

Data Source

PatentUS12263467B2Mixed mode cation exchange chromatography ligands based on 1,3-dioxoisoindolin-2-yl structures
Publication Date: 2025.04.01 BIO RAD LABORATORIES INC
  • US12263467B2 patent drawing
  • US12263467B2 patent drawing
  • US12263467B2 patent drawing

AI summary

The subject invention pertains to proteins are purified by a mixed-mode chromatography system formed by attaching a ligand with cation exchange and hydrophobic 1,3-dioxoisoindolin-2-yl group functionalities to a large-pore support matrix, the only linkage between the ligand and the support matrix being a chain having a backbone of one, two, three, four, or five atoms between the hydrophobic group and the support matrix.